The e-Button -- Data Everywhere
Robert J. Sclabassi, MD, PhD, CEO
Computational Diagnostics, Inc.
Friday March 30, 2012
2:00 pm - Sennott Square - Seminar Room 5317
The eButton, was developed with support from the NIH Genes, Environment and Health Initiative (U01HL91736, Mingui Sun (PI)) to study environmental exposure, with particular emphasis on diet, physical activity and lifestyle. The eButton is a miniature wearable sensing device the heart of which is a RISC CPU running a Linux/Android operating system and which hosts a number of sensors including video cameras, a GPS chip, an accelerometer, a gyroscope, a UV sensor, an electronic compass and an audio sensor. The integration of physiological sensors for measuring heart rate, respiration, blood pressure, and blood glucose level have also been investigated. The eButton has many applications including evaluating diet and physical activity; safety and well being of the elderly, children, and people with chronic health conditions such as diabetes, heart disease, respiratory disease, dementia, and mental disorders. It can also be utilized by the police, insurance companies, parking enforcement, disaster rescue personnel to document events automatically and coordinate actions; by blind people to find their ways; by operators of large vehicles or important systems to ensure alertness and avoid accidents; by soldiers to coordinate joint operations; by tourists to fully record their day, and by trainers to evaluate the effectiveness of trainees. The advanced design allows eButton to be small, light weight and attractive for people to wear. Its powerful software platform allows the user to either develop or download application software (apps) for their needs, just as with a smart phone Extensive software has been developed to provide off-line analysis of collected data. We conceive of the eButton is the beginning of a new era of ubiquitous information technology. Bill Gates put a computer in your home. Steve Jobs put a computer in your pocket and we are putting a computer on you.
Robert J. Sclabassi, MD, Ph.D. currently serves as CEO of Computational Diagnostics, Inc., a company he founded in 1989. With a strong background in engineering, business, medicine, and research, Dr. Sclabassi forged a career utilizing a multidisciplinary approach to create revolutionary medical technologies. He received a Ph.D. in electrical engineering from the University of Southern California, and a medical degree from the University of Pittsburgh. He did post-graduate work at The Brain Institute of UCLA where he studied clinical neurophysiology.
Dr. Sclabassi has extensive clinical and educational experience in the fields of engineering, neuroscience, and neurosurgery, among others. He has served as a professor and researcher at the University of California - Los Angeles, University of Pittsburgh, and Carnegie Mellon University. At the University of Pittsburgh, Dr. Sclabassi served as the director for both the Lab for Computational Neuroscience and the Center for Clinical Neurophysiology. As a clinician, he served on the medical staff of numerous hospital systems--including the University of Pittsburgh Medical Center, the Veteran's Administration Hospital - Oakland, St. Margaret's Hospital, Altoona Regional Hospital, and St. John's Hospital. Currently, Dr. Sclabassi's practice is limited to intra operative monitoring, a field that he has pioneered and has over 30 years of experience. He is licensed to practice medicine in Pennsylvania, Missouri, and telemedicine in New Mexico.
In the world of research and academia, Dr. Sclabassi is internationally known. He has published over 150 journal papers, 220 refereed conference papers, 55 book chapters, 200 conference abstracts, 200 invited presentations, and holds 15 patents. He has also served as a consultant for the National Institutes of Health, National Science Foundation and N.A.S.A.
Dr. Sclabassi previously worked for TRW Systems Group, was a founder of LimTech, Inc., and now serves as a consultant to many medical device companies. He was an innovator in the use of telemedicine applied to neurophysiology and has twice received recognition from the Computerworld Smithsonian Awards for the development of a Real-Time Intraoperative Monitoring System. This technology was described in Tom Peters' book Liberation Management as the wave of the future. The rights to this technology were obtained from the University of Pittsburgh under the name NeuroNet and has formed the backbone of CDI's evolving technology. Currently, Dr. Sclabassi serves on the Boards of Neuro Kinetics,Inc., Decision Resources, Inc., Pittsburgh Opera, and the Regents of LMU/LA